<DOC>
	<DOCNO>NCT01698970</DOCNO>
	<brief_summary>A double-blind , multicentre , stratify centre , randomise , parallel study two group adult patient operate Crohn 's disease , determine oral ingestion probiotic could prevent appearance Crohn 's disease recurrent endoscopic ileo-colonic lesion 12 month surgery . Patients consume 900 mg/day active product ( N=56 ) control product ( N=56 ) one year .</brief_summary>
	<brief_title>Effect Consumption Probiotic Strain Prevention Post-operative Recurrence Crohn 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Male/female least 18 year old Diagnosis Crohn 's disease define criterion usually adopt ( GowerRousseau , 1994 ) Crohn 's disease mainly limit terminal ileum and/or ascend transverse colon Diagnosis Crohn 's disease agreement surgical specimen analysis Patient give write consent take part study Complete resection main macroscopic ileocolonic lesion , show inspection surgery To ileocolic resection ( right , transverse , leave ) anastomosis inspect endoscopy Ability start oral nutrition therefore consumption study product within 21 day surgery Patient receive antibiotic begin product consumption One intestinal resection 5 last year last surgery Presence severe additional disease For female patient : pregnancy breast feeding For premenopausal female patient : effective contraceptive method use ( combined oestrogenprogestogen pill Intrauterine Device ) Patient currently exclusion period follow participation another clinical trial Patient situation investigator 's opinion could interfere optimal participation present study could constitute special risk patient Significant presence Crohn 's disease intestinal tract Small bowel cumulative resection exceed 1 meter Patient ileostomy Subtotal colectomy ileorectal anastomosis Severe postoperative septic complication ( fistula , peritonitis ) , lead administration 15 day postoperative antibiotherapy ) Intake unauthorised treatment ( mesalazine , olsalazine sulfasalazine , 5Aminosalicylates ( 5ASA ) 4Aminosalicylates ( 4ASA ) ) ; cortico√Øds immunosuppressor ) surgery except corticoid stop within 6 week surgery accord standardise stepwise dose reduction Patient artificial nutrition Subject loss personal liberty , administrative judicial decision , major legal guardian</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Probiotic</keyword>
	<keyword>capsule</keyword>
	<keyword>Crohn 's disease</keyword>
	<keyword>recurrent endoscopic ileo-colonic lesion</keyword>
</DOC>